Indirect Regulation of PTH by Estrogens May Require FGF23

被引:78
作者
Carrillo-Lopez, Natalia [1 ]
Roman-Garcia, Pablo [1 ]
Rodriguez-Rebollar, Ana [1 ]
Luis Fernandez-Martin, Jose [1 ]
Naves-Diaz, Manuel [1 ]
Cannata-Andia, Jorge B. [1 ]
机构
[1] Univ Oviedo, Hosp Univ Cent Asturias, Inst Reina Sofia Invest, Bone & Mineral Res Unit,REDinREN ISCIII, E-33006 Oviedo, Asturias, Spain
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2009年 / 20卷 / 09期
关键词
PARATHYROID-HORMONE SECRETION; VITAMIN-D METABOLISM; RETINOID-X-RECEPTOR; POSTMENOPAUSAL WOMEN; 1,25-DIHYDROXYVITAMIN-D RECEPTORS; SECONDARY HYPERPARATHYROIDISM; BIOCHEMICAL MARKERS; MINERAL METABOLISM; BONE LOSS; IN-VITRO;
D O I
10.1681/ASN.2008121258
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The mechanisms by which estrogens modulate PTH are controversial, including whether or not estrogen receptors (ERs) are present in the parathyroid glands. To explore these mechanisms, we combined a rat model of CKD with ovariectomy and exogenous administration of estrogens. We found that estrogen treatment significantly decreased PTH mRNA and serum levels. We did not observe ER alpha or ER beta mRNA or protein in the parathyroids, suggesting an indirect action of estrogens on PTH regulation. Estrogen treatment significantly decreased serum 1,25(OH)(2) vitamin D-3 and phosphorus levels. In addition, estrogens significantly increased fibroblast growth factor 23 (FGF23) mRNA and serum levels. In vitro, estrogens led to transcriptional and translational upregulation of FGF23 in osteoblast-like cells in a time- and concentration-dependent manner. These results suggest that estrogens regulate PTH indirectly, possibly through FGF23.
引用
收藏
页码:2009 / 2017
页数:9
相关论文
共 51 条
[31]   EXPERIMENTAL UREMIA - DESCRIPTION OF A MODEL PRODUCING VARYING DEGREES OF STABLE UREMIA [J].
ORMROD, D ;
MILLER, T .
NEPHRON, 1980, 26 (05) :249-254
[32]   Aromatase deficiency causes altered expression of molecules critical for calcium reabsorption in the kidneys of female mice [J].
Oz, Orhan K. ;
Hajibeigi, Asghar ;
Howard, Kevin ;
Cummins, Carolyn L. ;
Van Abel, Monique ;
Bindels, Rene J. M. ;
Word, R. Ann ;
Kuro-o, Makoto ;
Pak, Charles Y. C. ;
Zerwekh, Joseph E. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (12) :1893-1902
[33]  
Parker MG, 1998, BIOCHEM SOC SYMP, P45
[34]   Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1α-hydroxylase expression in vitro [J].
Perwad, Farzana ;
Zhang, Martin Y. H. ;
Tenenhouse, Harriet S. ;
Portale, Anthony A. .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2007, 293 (05) :F1577-F1583
[35]   Combination therapy for treatment of osteoporosis: A review [J].
Pinkerton, JoAnn V. ;
Dalkin, Alan C. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (06) :559-565
[36]   LACK OF EVIDENCE FOR ESTROGEN-RECEPTORS IN HUMAN AND BOVINE PARATHYROID TISSUE [J].
PRINCE, RL ;
MACLAUGHLIN, DT ;
GAZ, RD ;
NEER, RM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (06) :1226-1228
[37]   Pathogenesis of osteoporosis: concepts, conflicts, and prospects [J].
Raisz, LG .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (12) :3318-3325
[38]   Sex steroids and the construction and conservation of the adult skeleton [J].
Riggs, BL ;
Khosla, S ;
Melton, LJ .
ENDOCRINE REVIEWS, 2002, 23 (03) :279-302
[39]   Hormonal replacement therapy in an animal model with chronic renal failure and ovariectomy:: Biochemical and densitometric study [J].
Rodríguez-Rodríguez, A ;
Naves, M ;
Rodríguez-Rebollar, A ;
Gómez, C ;
Braga, S ;
Cannata-Andía, JB .
KIDNEY INTERNATIONAL, 2003, 63 :S57-S61
[40]   MEASUREMENT OF ESTROGEN AND PROGESTERONE RECEPTORS IN ABNORMAL HUMAN PARATHYROID TISSUE [J].
SAXE, AW ;
GIBSON, GW ;
RUSSO, IH ;
GIMOTTY, P .
CALCIFIED TISSUE INTERNATIONAL, 1992, 51 (05) :344-347